Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | L-Glutamic Acid | HCID 33032 | — |
| Reactant | Lorcaserin | HCID 11658860 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Isopropyl Acetate | HCID 7915 | — |
| Solvent | Water ethanol | HCID 19096565 | — |
| Product | HCID 56929575 | HCID 56929575 | — |
Reaction Steps
(R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine L-glutamate salt was prepared by addition of L-glutamic acid (0.5-1 eq.) in hot EtOH/H2O (˜2:1) to a solution of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine in isopropyl acetate, followed by evaporation of the solvent overnight to produce a solid. The solid was slurried in isopropyl acetate and then isolated by filtration. Alternatively, (R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine L-glutamate salt was prepared by addition of a solution of L-glutamic acid (1 eq.) in hot H2O to a solution of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine. The product crystallized without the need for evaporation of the solvent. (R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine L-glutamate salt had an extrapolated melting onset temperature by DSC of about 187° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08999970B2 |
|---|
| Source dataset | uspto-grants-2015_04 |
|---|
| ORD ID | ord-1cc7bae5af1e4bef99c97a92a6888992 |
|---|
| Source note | uspto-grants-2015_04 |
|---|